Identification of fibronectin neoepitopes present in human osteoarthritic cartilage - PubMed (original) (raw)
. 2006 Sep;54(9):2912-22.
doi: 10.1002/art.22045.
Affiliations
- PMID: 16948117
- DOI: 10.1002/art.22045
Free article
Identification of fibronectin neoepitopes present in human osteoarthritic cartilage
Marc D Zack et al. Arthritis Rheum. 2006 Sep.
Free article
Abstract
Objective: Fibronectin fragments are present at high concentrations in the cartilage of patients with rheumatoid arthritis and patients with osteoarthritis (OA) and have been shown to promote cartilage catabolism in human cartilage cultures, suggesting that fibronectin fragments participate in the initiation and progression of arthritic disease. This study was undertaken to 1) identify the major fibronectin fragments in human OA cartilage and confirm their ability to elicit cartilage catabolism, 2) identify the cleavage sites in fibronectin and generate the corresponding neoepitope antibodies, and 3) explore the utility of fibronectin neoepitopes as biomarkers.
Methods: Fibronectin fragments were purified from human OA cartilage using affinity chromatography; their N-termini were then identified by sequencing. Bovine nasal cartilage was treated with affinity-purified fibronectin fragments and assayed for aggrecan breakdown by monitoring the release of glycosaminoglycans and the aggrecan neoepitope 1771AGEG. Fibronectin neoepitopes were detected by Western blotting in cytokine-treated media of human cartilage explants, and by immunohistochemical analyses of human OA cartilage.
Results: Multiple fibronectin fragments were isolated from human OA cartilage, and all contained the N-terminus 272VYQP. These fragments induced aggrecanase-mediated cartilage catabolism in bovine cartilage explants. Fibronectin fragments with the N-terminus 272VYQP and fragments with the C-terminus VRAA271 were detected following cytokine treatment of human cartilage extracts. These neoepitopes localized with areas of aggrecan loss in OA cartilage.
Conclusion: Human OA cartilage contains fibronectin fragments with catabolic activity and a major cleavage site within fibronectin. This study is the first to characterize fibronectin neoepitopes in OA cartilage, suggesting that they may represent a novel biomarker of arthritis.
Similar articles
- Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS. Lark MW, et al. J Clin Invest. 1997 Jul 1;100(1):93-106. doi: 10.1172/JCI119526. J Clin Invest. 1997. PMID: 9202061 Free PMC article. - ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala(271).
Zack MD, Malfait AM, Skepner AP, Yates MP, Griggs DW, Hall T, Hills RL, Alston JT, Nemirovskiy OV, Radabaugh MR, Leone JW, Arner EC, Tortorella MD. Zack MD, et al. Arthritis Rheum. 2009 Sep;60(9):2704-13. doi: 10.1002/art.24753. Arthritis Rheum. 2009. PMID: 19714641 - Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K. Glant TT, et al. Arthritis Rheum. 1998 Jun;41(6):1007-18. doi: 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6. Arthritis Rheum. 1998. PMID: 9627010 - Osteoarthritis: cellular and molecular changes in degenerating cartilage.
Lorenz H, Richter W. Lorenz H, et al. Prog Histochem Cytochem. 2006;40(3):135-63. doi: 10.1016/j.proghi.2006.02.003. Epub 2006 Mar 23. Prog Histochem Cytochem. 2006. PMID: 16759941 Review. - Fibronectin, cartilage, and osteoarthritis.
Chevalier X. Chevalier X. Semin Arthritis Rheum. 1993 Apr;22(5):307-18. doi: 10.1016/s0049-0172(05)80010-1. Semin Arthritis Rheum. 1993. PMID: 8511595 Review.
Cited by
- Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities.
Long DL, Ulici V, Chubinskaya S, Loeser RF. Long DL, et al. Osteoarthritis Cartilage. 2015 Sep;23(9):1523-31. doi: 10.1016/j.joca.2015.04.019. Epub 2015 Apr 29. Osteoarthritis Cartilage. 2015. PMID: 25937027 Free PMC article. - H2O2 oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes.
Nelson KJ, Bolduc JA, Wu H, Collins JA, Burke EA, Reisz JA, Klomsiri C, Wood ST, Yammani RR, Poole LB, Furdui CM, Loeser RF. Nelson KJ, et al. J Biol Chem. 2018 Oct 19;293(42):16376-16389. doi: 10.1074/jbc.RA118.004613. Epub 2018 Sep 6. J Biol Chem. 2018. PMID: 30190325 Free PMC article. - A Comparative Study of Fibronectin Cleavage by MMP-1, -3, -13, and -14.
Zhang X, Chen CT, Bhargava M, Torzilli PA. Zhang X, et al. Cartilage. 2012 Jul;3(3):267-77. doi: 10.1177/1947603511435273. Cartilage. 2012. PMID: 26069638 Free PMC article. - Analysis of Endogenous Peptides Released from Osteoarthritic Cartilage Unravels Novel Pathogenic Markers.
Fernández-Puente P, González-Rodríguez L, Calamia V, Picchi F, Lourido L, Camacho-Encina M, Oreiro N, Rocha B, Paz-González R, Marina A, García C, Blanco FJ, Ruiz-Romero C. Fernández-Puente P, et al. Mol Cell Proteomics. 2019 Oct;18(10):2018-2028. doi: 10.1074/mcp.RA119.001554. Epub 2019 Jul 27. Mol Cell Proteomics. 2019. PMID: 31352363 Free PMC article. - Monitoring cartilage turnover.
Charni-Ben Tabassi N, Garnero P. Charni-Ben Tabassi N, et al. Curr Rheumatol Rep. 2007 Apr;9(1):16-24. doi: 10.1007/s11926-007-0017-y. Curr Rheumatol Rep. 2007. PMID: 17437662 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical